Showing results (71-80 of 115) with videos related to
Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|August 23, 2005
Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cellsRinat Eshel, Olga Ben-Zaken, Oded Vainas, et al.Haematologica|February 4, 2017
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemiaMika Shapiro, Yair Herishanu, Ben-Zion Katz, et al.European Journal of Haematology|February 20, 2014
Serum immunoglobulin levels at diagnosis have no prognostic significance in stage A chronic lymphocytic leukemia: a study of 1113 cases from the Israeli CLL Study GroupLev Shvidel, Tamar Tadmor, Andrei Braester, et al.Annals of Hematology|January 1, 2013
Pathogenesis, prevalence, and prognostic significance of cytopenias in chronic lymphocytic leukemia (CLL): a retrospective comparative study of 213 patients from a national CLL database of 1,518 casesLev Shvidel, Tamar Tadmor, Andrei Braester, et al.European Journal of Haematology|October 5, 2012
Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study GroupOsnat Bairey, Neta Goldschmidt, Rosa Ruchlemer, et al.Annals of Medicine|September 6, 2016
Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemiaYair Herishanu, Aaron Polliack, Shani Shenhar-Tsarfaty, et al.Experimental Hematology|February 2, 2002
Heparanase expression in human leukemias is restricted to acute myeloid leukemiasMenachem Bitan, Aaron Polliack, Gabriella Zecchina, et al.Leukemia Research|February 12, 2013
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomasAlessia Bari, Tamar Tadmor, Stefano Sacchi, et al.Annals of Hematology|May 25, 2012
Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patientsLev Shvidel, Andrei Braester, Osnat Bairey, et al.The Israel Medical Association Journal : IMAJ|February 12, 2014
JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood countsNadav Sarid, Rinat Eshel, Einam Rahamim, et al.Pageof 12